A3P International Congress
Process control and product life cycle: QbD, CPV, Statistical, Analytical / Annex1 - feedback and implementation / Environmental performance
Location
Espace Bellevue, Biarritz (France)
Date
10, 11 & 12 October 2023
Save The Date !
Format
Conferences, workshops, exhibition
Share
Official language of the conferences : French
Simultaneous translation of the conferences: French <-> English
Simultaneous translation of the conferences: French <-> English
Tuesday, October 10th
Welcome of the participants
08:00
A word from the president
Jacques NAVELLOU
09:00
Introduction to the "Process Control and Product Life Cycle" session
Anne RIGOULOT - DELPHARM
09:15
An integrated approach for product lifecycle robustness
Elodie KEROMNES - STALLERGENES & Sandrine DUCLOS - VIRBAC & Alain NONN - HUMANIM & Gérald DEFONTENAY - TERANGA GROUPE - CEBIPHAR & Catherine TUDAL - SOLADIS
Representatives of the A3P GICs: Qbd & CPV & Analytical & Statistical
Representatives of the A3P GICs: Qbd & CPV & Analytical & Statistical
09:30
Differences and interactions between CPV and APR
Véronique BRIANTO-GABIER – MAAT PHARMA & Michel HERTSCHUH – AKTEHOM
Representatives of the A3P CPV GIC
Representatives of the A3P CPV GIC
10:00
Coffee break on the exhibition
10:30
Quality by Design - A US FDA Perspective
Karyn CAMPBELL - ABBVIE
11:30
Ongoing Analytical Procedure Performance Verification
Phil BORMAN - GSK
12:00
Lunch
12:30
Analytical Method Life Cycle Driven by Ruggedness Study
Mourad MELLAL - CATALENT
14:30
Digital QbD-Based Process Development and Control Strategy: Methodologies and Implementation
Yash SABHARWAL - QBDVISION & Ane QUESADA GANUZA - VIRALGEN VECTOR CORE
15:00
Coffee break on the exhibition
15:30
Introduction to the "Annex1" session
Julien TRIQUET - CSL BEHRING
16:30
A South African journey to Annex 1 realisation: shared perspective from two aseptic manufacturing companies
Melinda OTT & Wien PIETERS - ASPEN
16:45
APS Design according to the New Annex 1 - Process Control or Process Monitoring
Jérôme WEISZ – NOVO NORDISK & Pierre DEVAUX – THERAXEL
17:15
Feedback on sterilization indirect contact parts
Patrizia MUSCAS - LILLY
17:45
Cocktail on the exhibition
18:15
Wednesday, October 11th
A3P Human Breakfast "The incredible journey of Dr. Denis Mukwege, the world-renowned gynecological surgeon, Nobel Peace Prize winner, founder and medical director of the Panzi Hospital and Foundation."
A3P Human will be presenting the ecosystem that revolves around Dr. Mukwege and the challenges of the mission: from the supply of medicines to the facilities and capacity for care.
The experience of treating women has led Dr. Mukwege to his life's mission: to increase the protection of survivors of sexual violence, and to bring to justice the perpetrators of such violence and those who condone it.
Dr Mukwege is also a member of the Advisory Board of the International Campaign to End Rape and Gender-Based Violence in Conflict. He has received numerous awards, including the 2018 Nobel Peace Prize.
His eco-system consists of a 450-bed hospital, a central pharmacy, a research and training center, a mobile unit and much more... Doctor Mukwege has created a holistic model with 4 pillars, which will be presented to us:
1. Saving lives
2. Repairing souls
2. Gaining independence
3. Demanding justice
A3P Human wishes to highlight his actions, facilitate encounters with the pharma sector and enable everyone to get to know, participate in, donate to, help and support the Panzi Foundation; whether through donations, facilitating access to medicines, care equipment, ... they need us.
https://www.linkedin.com/company/panzi-foundation/
https://fr.wikipedia.org/wiki/Denis_Mukwege
The experience of treating women has led Dr. Mukwege to his life's mission: to increase the protection of survivors of sexual violence, and to bring to justice the perpetrators of such violence and those who condone it.
Dr Mukwege is also a member of the Advisory Board of the International Campaign to End Rape and Gender-Based Violence in Conflict. He has received numerous awards, including the 2018 Nobel Peace Prize.
His eco-system consists of a 450-bed hospital, a central pharmacy, a research and training center, a mobile unit and much more... Doctor Mukwege has created a holistic model with 4 pillars, which will be presented to us:
1. Saving lives
2. Repairing souls
2. Gaining independence
3. Demanding justice
A3P Human wishes to highlight his actions, facilitate encounters with the pharma sector and enable everyone to get to know, participate in, donate to, help and support the Panzi Foundation; whether through donations, facilitating access to medicines, care equipment, ... they need us.
https://www.linkedin.com/company/panzi-foundation/
https://fr.wikipedia.org/wiki/Denis_Mukwege
07:30
Break
8:30
Beginning of the workshops at Espace Bellevue & Casino Municipal
The aim of the workshops is to raise awareness or to deepen theoretical or practical notions with the help of case studies that the participants must deal with during a workshop in order to propose solutions in the form of conclusions, written with the help of the expert facilitators. The workshop group is made up of an A3P manager (or moderator) from the Board of Directors, two facilitators chosen for their recognized skills (1 manufacturer and 1 supplier) and congress participants or exhibitors who have registered by name.
During one day, the participants will exchange, work and debate around a technical or regulatory theme.
Registering for the Congress allows you to participate in one of the 17 workshops that will be presented this year (subject to availability)
During one day, the participants will exchange, work and debate around a technical or regulatory theme.
Registering for the Congress allows you to participate in one of the 17 workshops that will be presented this year (subject to availability)
09:30
Cofee break on the exhibition
10:30
Continuation of the first part of the workshop
11:30
Lunch cocktail in the exhibition
12:30
Second part of the workshop
14:00
Cofee break on the exhibition
16:00
Continuation of the second part of the workshop
End around 18h
16:30
Gala Dinner
Formal wear required.
20:00
Thursday, October 12th
Welcome of the participants
08:15
Technical realities of airborne particle sampling techniques. Use of the established scientific consensus as summarised in ISO Technical Report 14644-21 to understand and respond to requirements of new EU-PIC/S GMP Annex. An example of theoretical and experimental assessment of performance capability of a sampling configuration for continous monitoring of a grade A isolator filling line
John HARGREAVES - JHAC & Olivier BROUSTE - AEROLAB
08:45
Discussions on the new Annex 1 GMP Eu. Update on the implementation process. Discussions on several points of interest identified by A3P and encountered during inspections
Lu-Jie FERRE - ANSM
09:15
Annex 1 GMP Eu, discussions around several points of interest collected by A3P and encountered during inspections
Matt DAVIS - TGA (Therapeutic Goods Administration - Australian)
10:00
Coffee break on the exhibition
10:30
Introduction to the "Environmental Performance" session
Samah RINGA - VEOLIA
11:15
Famar Journey to Energy Efficiency and emission reduction
Nadia BALDOIN - FAMAR
11:30
Reduction of the water footprint on an injectable production site
Xavier ROQUES & Robinson Luiz MORAIS - NOVO NORDISK
11:50
GSK Sustainability Agenda and our approach to Zero Waste
Ilaria Lo PRESTI - GSK
12:10
Question and answer
Nadia BALDOIN - FAMAR / Xavier ROQUES & Robinson Luiz MORAIS - NOVO NORDISK / Ilaria Lo PRESTI - GSK
12:30
Closing of the 2023 Congress and lunch at the Casino
13:00
What is a workshop ?
Raise awareness or deepen theoretical or practical notions with the help of case studies that the participants must handle during a workshop in order to propose solutions in the form of conclusions, written with the help of the expert facilitators.
The workshop group is composed of an A3P leader (or moderator) from the Board of Directors, two facilitators chosen for their recognized skills (1 manufacturer and 1 supplier) and attendees or exhibitors who have signed up by name.
Over the course of a day, participants will exchange, work and debate on a technical or regulatory theme.
Registration for the Congress allows you to participate in one of the 17 workshops that will be presented this year ( within the limits of available places). List of workshops below.
✻
Contamination Control Strategy : what evolutions after several months of development of the concept and use of the guides and template ? - Workshop full
Facilitators : Nicolas Bourgeois - SANOFI & Pierre DEVAUX - THERAXEL
Moderator : Julien TRIQUET - CSL BEHRING
- Feedback on the use of the A3P guideline and template by the industry, published in January 2023
- Practical and operational answers to the problems encountered on the sites
- Work on CCS lifecycle management / performance management / Dashboard / KPIs to be developed in the context of continuous improvement
Workshop 1
Aseptic Process Simulation vs. EU GMP Annex 1 expectations: interpretation and implementation challenge - Workshop full
Facilitators : Virginie LEFERE & Isabelle HOENEN - LILLY & Benoit FRANQUIN - CSL BEHRING
Moderator : Dominique SIERAKOWSKI - DS ASEPTIC COMPLIANCE
Presentation of the APS requirements of Annex 1 - 2022 including the points that are sources of difficulties for understanding, interpretation and implementation. Focus on the TOP 6 of these points based on a survey published before the congress.
Workshop including a reminder of the APS requirements in Annex 1, feedback from the survey published prior to the conference and work in sub-groups on the TOP 6 of these interpretation and/or implementation issues. The day will conclude with an open roundtable/Q/A session with the expert facilitators.
Workshop including a reminder of the APS requirements in Annex 1, feedback from the survey published prior to the conference and work in sub-groups on the TOP 6 of these interpretation and/or implementation issues. The day will conclude with an open roundtable/Q/A session with the expert facilitators.
Workshop 2
Prevention of contamination during aseptic or sterile production: practical case studies - Workshop full
Facilitators : Patrizia MUSCAS - ELI LILLY ITALIA & Walid EL AZAB - STERIS
Moderator : Sophie AMADIO - LILLY
This workshop in English is intended to provide discussions, sharing knowledge around the contamination control program to establish on complete parenteral manufacturing process (starting from drug substance thawing until primary packaging).
This workshop is intended for everyone, intermediate to experienced level, and should allow participants to analyze and discuss the critical aspects of the sterile process, to consider various situations of real cases failure that can occur.
Under realistic conditions, the workshop will lead the participants to consider a complete contamination control program, to discover real contamination situations, to search and define together effective CAPA.
Whenever possible, the workshop will illustrate the feedback with the expectation of the new Annex 1.
This workshop is intended for everyone, intermediate to experienced level, and should allow participants to analyze and discuss the critical aspects of the sterile process, to consider various situations of real cases failure that can occur.
Under realistic conditions, the workshop will lead the participants to consider a complete contamination control program, to discover real contamination situations, to search and define together effective CAPA.
Whenever possible, the workshop will illustrate the feedback with the expectation of the new Annex 1.
Workshop 3
Compliance of decontamination processes applied to surfaces inside our Technologies Barriers in indirect contact with the product - Workshop full
Facilitators : Aurélie GROULT-LEROY – SANOFI LE TRAIT & Elodie PASTRE - THERAXEL
Moderator : Christophe EMONARD - BIOMERIEUX
The validation of decontamination processes applied to aseptic distribution lines is a requirement well described in the new European GMP Annex 1 in chapter 4 "Premises" and its sub-section on Barrier Technologies. The management of indirect product contact surfaces is an integral part of this strategy and must integrate the requirements of paragraph 5.5 of the new Annex 1 within the "Equipment" chapter. What surfaces are we talking about? How do we deal with the different configurations of our aseptic distribution lines? How can the CCS concept be used to justify the implemented strategy and thus optimize the Cleaning/Disinfection strategies of our Class A critical area surfaces, in order to achieve the required level of Sterility Assurance immediately before starting production?
Workshop 4
Annex 1 and Contamination Control in cleanrooms: How to link your biocleaning program with the Environmental Monitoring of the zones - Workshop full
Facilitators : Ségolène CHARRAT - COPHACLEAN & Marion ROUSSET - LABORATOIRE VIRBAC
Moderator : Didier MEYER - DMCOMPLIANCE
In the context of the publication of the new Annex 1, this workshop will aim at bringing the participants to reflect on two essential subjects in terms of contamination control: biocleaning and environmental monitoring. Also, in the context of the writting of the CCS, a reflection will be carried out on the tools to ensure the control of contamination and on the way to combine them to obtain a more conclusive level of information. Thus, Annex 1, as it is constructed, encourages a risk analysis approach, whether to establish a biocleaning program or an environmental monitoring program. The challenge is therefore to bring the participants to design, in a risk analysis approach, an efficient biocleaning program whose possible failures could be highlighted through the environmental monitoring.
Objectives :
Objectives :
- How to determine the adequacy of the biocleaning program through the results of the environmental monitoring
- How to ensure that the environmental monitoring program can identify biocleaning failures
Workshop 5
Déploiement de la démarche CPV pour un atelier de répartition aseptique
Animateurs : Membres du GIC A3P CPV
Modérateur : Christophe BENOIT - ROMMELAG
- Continued Process Verification (CPV) is part of stage 3 of the lifecycle management of a drug. The objective of this CPV is to provide evidence that the manufacturing process is operating under control state and consistently generates product which meets its predetermined requirements throughout the drug life cycle. This evaluation is done by trending and analyzing data to identify opportunities for process improvement.
- The objective of the workshop "Deployment of the CPV activity for an aseptic repartition workshop" is to realize the deployment of the CPV activity from the identification of the parameters to be followed, the application of the statistical tools and the data analysis, identification and implementation of the corrective actions.
Workshop 6
Implementation of a retro QbD: challenges, risks or opportunities?
How to identify and control them in relation to continuous process control (CPV)?
How to identify and control them in relation to continuous process control (CPV)?
Facilitators : Members of the A3P QbD and CPV GICs
Moderator : Vincent GRIFFOUL - STALLERGENES
Interactive theoretical presentations on the following topics
Working together on the advantages, risks and drawbacks of the retro QbD approach: 1 practical case study in sub-groups
- Risk benefits: how to argue for a retro QbD approach? experience feedback
- Setting up retro QbD: What data do I need? How to use it?
- Steps to follow, Pitfalls to avoid
- Continuous Process Verification (CPV)
Working together on the advantages, risks and drawbacks of the retro QbD approach: 1 practical case study in sub-groups
- The aim of the workshop is to consider the various possible options, to select one for each group, and to define the various stages, with their advantages/disadvantages, up to the implementation of the retro QbD.
- The case study will be studied by capitalizing on theoretical and practical knowledge with a concern for balance, cost/benefit, and will be presented to management represented by GIC members..
Workshop 7
How to approach a change of scale using the QBD approach?
Facilitators : Members of the A3P QbD GIC
Moderator : Jean-Louis BELMON - VIRBAC
- Position of scaling in the QBD process
- Case study of an injectable biotech and a dry form
- The challenges of scale-up and the contribution of QbD
Workshop 8
Awareness of Design of Experiments (DoE) as an effective QbD tool
Facilitators : Mourad MELLAL - CATALENT & Catherine TUDAL - SOLADIS BY EFOR
Moderator : Anne RIGOULOT - DELPHARM
In this workshop, the magic of multifactorial Design of Experimental will be revealed through a fun physical experiment. After going through some basic notions of experimental design, the elasticity of bouncing balls will be explored. Participants will have the opportunity to construct and analyze a design of experiment, and are sure to be amazed by the results! There are no prerequisites for this workshop. Trainees should bring a laptop PC, equipped with software for experimental design. Free trial versions of software are available from JMP or Minitab, for example.
Workshop 9
AQbD : a pragmatic and practical set up
Facilitators : Gérald De Fontenay - TERANGA GROUPE / CEBIPHAR & Marc FRANÇOIS-HEUDE - SANOFI
Moderator : Pierre ANDRE - LEO PHARMA
Our mascot, created for this workshop, will drive us throughout the day!
For analytical purposes, draft ICH guidelines Q14/Q2(R2) and USP chapter 1220 provide numerous recommendations for an improved approach for a better analytical procedure life cycle management.
But how to set up properly this approach ? With who?
The concrete and tasty approach of this workshop will draw a parallel with daily activities, in order to illustrate clearly the interest of the concept and corresponding tools.
Note: microbiological methods are out of the scope of this workshop
For analytical purposes, draft ICH guidelines Q14/Q2(R2) and USP chapter 1220 provide numerous recommendations for an improved approach for a better analytical procedure life cycle management.
But how to set up properly this approach ? With who?
The concrete and tasty approach of this workshop will draw a parallel with daily activities, in order to illustrate clearly the interest of the concept and corresponding tools.
Note: microbiological methods are out of the scope of this workshop
Workshop 10
Path to zero carbon , How pharma industry can face the challenge
Facilitators : Sandra NIETO - HALEON & Farida DOULAMI - VEOLIA
Moderator : Samah RINGA - VEOLIA
The pharmaceutical industry is responsible for a significant carbon footprint.
In this workshop, we explore decarbonization opportunities and focus on strategies for implementing sustainable practices while preserving the quality of the end-product.
After a few reminders on the methodology for calculating the carbon balance, we identify, through a practical case, concrete actions that can reduce the carbon footprint and will examine technological innovations such as circular practices and energy efficiency, management of the water...etc.
We will also discuss the economic opportunities associated with the transition to a more sustainable pharmaceutical industry such as reducing energy costs.
The results of this workshop will serve as the basis for developing practical recommendations and strategic roadmaps for decarbonization.
In this workshop, we explore decarbonization opportunities and focus on strategies for implementing sustainable practices while preserving the quality of the end-product.
After a few reminders on the methodology for calculating the carbon balance, we identify, through a practical case, concrete actions that can reduce the carbon footprint and will examine technological innovations such as circular practices and energy efficiency, management of the water...etc.
We will also discuss the economic opportunities associated with the transition to a more sustainable pharmaceutical industry such as reducing energy costs.
The results of this workshop will serve as the basis for developing practical recommendations and strategic roadmaps for decarbonization.
Workshop 11
Investigations of microbiological-tests non-compliance or suspected non-compliance in pharmaceutical productions - Workshop full
Facilitators : Thierry Bonnevay - SANOFI & Arnaud Carlotti - EUROFINS
Moderator : Eric PETAT - TERANGA GROUPE - ACM PHARMA
Microbiological quality of pharmaceutical products is an essential component in the release of medicines. Microbiological analyses performed to ensure compliance with acceptance criteria are regulated and their results have great impact on the availability of drugs for patients. Any non-conformity is a significant event with multiple consequences: batch rejection (availability of the drug, costs), probable widespread impact (production capacity, costs), delicate investigation (time, costs), and a point of interest/concern for several years. It is therefore important to be certain that the problem exists, and if so, to identify its source and cause.
Following a presentation of the general principles that guide the conduct of investigations, participants will study three cases of proven or suspected microbiological non-compliance and the means of investigation available to us to document them in a robust and scientific manner. It will be necessary to define their exact status (proven/unproven), to explain the source, the cause and their impact in order to implement the appropriate corrective and preventive actions where necessary. In particular, we will consider the case of a "non-compliant BioBurden" analysis, a case of a possibly non-compliant PSA and finally a case of a possibly non-compliant sterility test, taken from real industrial situations. The aim will be to identify appropriate strategies for these three types of case and to develop a relevant approach to investigating OOS in microbiology.
Following a presentation of the general principles that guide the conduct of investigations, participants will study three cases of proven or suspected microbiological non-compliance and the means of investigation available to us to document them in a robust and scientific manner. It will be necessary to define their exact status (proven/unproven), to explain the source, the cause and their impact in order to implement the appropriate corrective and preventive actions where necessary. In particular, we will consider the case of a "non-compliant BioBurden" analysis, a case of a possibly non-compliant PSA and finally a case of a possibly non-compliant sterility test, taken from real industrial situations. The aim will be to identify appropriate strategies for these three types of case and to develop a relevant approach to investigating OOS in microbiology.
Workshop 12
Effective & efficient CSV : methodologies and tools
Facilitators : Pascale Mosnier - SERVIER & Pierre François Sambroni - CYRNOS CONSEIL & Hervé Cluzeaud - ASSYSTEM - EXPLEO GROUP
Moderator : Jean-Louis JOUVE - COETIC
Computerized System Validation (CSV) is often considered as a cumbersome and time-consuming workload. Why ? What are the main difficulties?
On the basis of a shared diagnostic, the workshop will aim to provide practical and pragmatic answers to these difficulties, based on project lifecycle framework when an aseptic production environment system is set up.
Solutions and practices collected during this workshop will enable participants to reuse tips to any other computerized system project implementation.
On the basis of a shared diagnostic, the workshop will aim to provide practical and pragmatic answers to these difficulties, based on project lifecycle framework when an aseptic production environment system is set up.
Solutions and practices collected during this workshop will enable participants to reuse tips to any other computerized system project implementation.
Workshop 13
Pharmaceutical waters: State of the art and future challenges - Workshop full
Facilitators : Aurelien PERIQUET - MERCK & Frederic MONNIER - VEOLIA WATER STI
Moderator : HERVE TASSERY - 5M PARTNER
After a brief reminder of the regulatory context, its latest evolutions and their impact in terms of design and monitoring mainly, the objective of this workshop will be to discuss the current and future challenges related to purified water and PPI.
It will be, indeed, a question of identifying solutions for a control of the physico-chemical and microbiological quality while combining the economic stakes and the strategies for a responsible and sustainable management of pharmaceutical waters.
The participants of this workshop will have the opportunity to share their experience and discuss the problems encountered in the management of their pharmaceutical water installations around a concrete case study.
It will be, indeed, a question of identifying solutions for a control of the physico-chemical and microbiological quality while combining the economic stakes and the strategies for a responsible and sustainable management of pharmaceutical waters.
The participants of this workshop will have the opportunity to share their experience and discuss the problems encountered in the management of their pharmaceutical water installations around a concrete case study.
Workshop 14
Engaging your teams to enhance your atractivity and employer positioning in a tensed context
Facilitators : Dominique BEN DHAOU - POINT NORTH & Nicolas QUOÊX - SKILLSPOTTING
Moderator : Anne HAYS - A3P ASSOCIATION
Tensions abound in today's economic world. The responsibilities that a manager carries are sometimes heavy and we are not always equipped to identify the motivation levers of our teams, to motivate ourselves, to defuse tensions, or even to anticipate them.
During this workshop, we will provide practical tools to mobilize teams, communicate about your vision and therefore position yourself as an employer of choice where talents are eager to flourish.
During this workshop, we will provide practical tools to mobilize teams, communicate about your vision and therefore position yourself as an employer of choice where talents are eager to flourish.
Workshop 15
LEAN management. No problem = no improvement.
Lean tools, the LEAN mindset and concrete solutions to increase performance - Workshop full
Lean tools, the LEAN mindset and concrete solutions to increase performance - Workshop full
Facilitators : Ronan le FLOC'H - SANOFI & Vincent PHILIBERT - QP PHARMA
Moderator : Christophe MEUNIER - AKTEHOM
LEAN management or the pleasure of solving problems TOGETHER. The LEAN management approach in terms of principles, state of mind, methodologies, tools, .... and the concrete benefits obtained will be presented, shared and also illustrated by your own situations.
No result without pleasure: this workshop will give you the pleasure to learn and understand TOGETHER why and how LEAN Management will help you improve your expected performance.
To take into account the feedback in terms of improvement from the previous 2 years, the content will be adjusted as follows:
Content
1. Introduction / Round table ==> Sharing among trainees
2. Theoretical contributions illustrated by practical and varied feedback
Feedback from facilitators and participants in terms of REX operational field
3. Implementation via a serious game - experimentation of performance improvements
Technical, organizational, methodological
4. Consolidation of the lessons learned from the exercise via a sequence focused on the state of mind, the methodology, and especially the Lean tools
Make learners aware of the lessons of the exercise
Transpose the keys into a memo (take-away) Specifics of this workshop:
No result without pleasure: this workshop will give you the pleasure to learn and understand TOGETHER why and how LEAN Management will help you improve your expected performance.
To take into account the feedback in terms of improvement from the previous 2 years, the content will be adjusted as follows:
Content
1. Introduction / Round table ==> Sharing among trainees
2. Theoretical contributions illustrated by practical and varied feedback
Feedback from facilitators and participants in terms of REX operational field
3. Implementation via a serious game - experimentation of performance improvements
Technical, organizational, methodological
4. Consolidation of the lessons learned from the exercise via a sequence focused on the state of mind, the methodology, and especially the Lean tools
Make learners aware of the lessons of the exercise
Transpose the keys into a memo (take-away) Specifics of this workshop:
- Serious game
- Contributions from participants prepared in advance
- MMemo containing the keys to effective implementation to use when returning to the company
workshop 16
Student workshop. A day of immersion in the pharmaceutical industry: EPPI water, environment and ZAC, control and quality, regulatory, production and pharmaceutical formatting
Facilitators : François MOREL – A3P ASSOCIATION & Sandrine FAVRE - OCTAPHARMA & Mats MICKOS – PHARMTEC & Gwenaëlle CLECH – 5M PARTNER & Bénédicte GAS - CHARLES RIVER
Moderator : Jonnathan TAFFORIN – A3P ASSOCIATION
The objective of this workshop is to come back to fundamental specificities of the pharmaceutical industry and essential for the future managers or executives in practice as well as to exchange with exhibitors on stands which will illustrate the presentations made.
During this day, four themes will be addressed:
During this day, four themes will be addressed:
- Air: filtration, clean rooms, air disinfection, clothing
- Liquids: Water production and distribution, filtration and SUU (Single Use System)
- Production equipment: filling lines, isolator and RABS (Restricted Access Barrier System), autoclave
- Quality: laboratory equipment, qualification/validation, services and advice
Workshop 17
Full exhibition
| Société | n°stand |
| ABC TRANSFER | O14 |
| AEROMETRIK | O6 |
| AKTEHOM | F19 |
| ALBHADES | R10BIS |
| AMSONIC – HAMO | R23 |
| ASSOCIATES OF CAPE COD | O36/O37 |
| ATRYON | O13 |
| AVN | K5 |
| BACCINEX | F6 |
| BATIMPRO CHARRIER | R12 |
| BAUSCH+STRÖBEL SE+CO. KG | R7 |
| BD | K16 |
| BECKMAN COULTER FRANCE | O22 |
| BIOMÉRIEUX | O43/O44 |
| BIOPHARMA TECHNOLOGIE FRANCE | B2 |
| BWT | O42 |
| CARBOGEN AMCIS | O38 |
| CARSO LSEHL | R9 |
| CCIT | K6 |
| CHARGEPOINT TECHNOLOGY | F8 |
| CHARLES RIVER | R26 |
| CHRISTEYNS | F4 |
| CONFORMAT | O2 |
| CONTEC | O9 |
| COPHACLEAN | O48 |
| CYTIVA | PALL | O16/O34 |
| DEVEA | R22 |
| ECOLAB | O18/O32/O33 |
| ELIS CLEANROOM | O24/O26 |
| ELLAB FRANCE | K4 |
| ENDRESS+HAUSER | R30 |
| EREA PHARMA | R29 |
| EUROFINS BIOPHARMA SERVICES | F15/F15BIS |
| FPS PHARMA | R15 |
| GASPOROX | R21 |
| GETINGE FRANCE | O10 |
| GIVE & TECH | O3/O4/O5 |
| GOMETROLOGIE | K14 |
| GROUPE ICARE | O11 |
| GROUPE PRODUCTLIFE | K10 |
| HEX + SAFYR | F1 |
| HOF SONDERANLAGENBAU | O50 |
| HONEYWELL – HPS | K17 |
| ILC DOVER | F10 |
| IMA FRANCE | F16 |
| INITIAL | O30 |
| INTERSCIENCE | F12 |
| INTERTEK FRANCE | O27 |
| IWT PHARMA | O42BIS |
| JBT BOURSIER | O21 |
| JCE BIOTECHNOLOGY | O51/O52 |
| KAYE / AMPHENOL | KO1 |
| KHUNER SHAKER | KO3 |
| KÖRBER PHARMA | O19 |
| LABORATOIRE HUCKERT’S INTERNATIONAL | R10 |
| LAPORTE EURO | R27 |
| LIVES INTERNATIONAL | F7 |
| LONZA COLOGNE | O45 |
| LSB – LA SALLE BLANCHE | R32 |
| LUCISBIO | O12 |
| MARCHESINI GROUP | B1 |
| MERCK | F13/F14 |
| MESALABS | R4 |
| MGA TECHNOLOGIES | O28 |
| NEOCERAM | K8 |
| NEOVIX BIOSCIENCES | K2 |
| NOVATEK INTERNATIONAL | R20 |
| OPTIMA PHARMA | O46 |
| ORION LIFE SCIENCES | KO4 |
| OXY’PHARM – SANIVAP | R25 |
| PARKER HANNIFIN FRANCE | R5 |
| PARTICLE MEASURING SYSTEMS | K18 |
| PEMFLOW | K9 |
| PFEIFFER VACUUM | O7 |
| PHARMAPLAN | R24 |
| PHARMASEP | O47 |
| PHARMTEC | O17 |
| PMT FRANCE | O23 |
| PQE FRANCE | KO5 |
| PROSYS GROUP | B4 |
| QESSE by NORDTEST | K15 |
| RAUMEDIC | K7 |
| REALCO | R14 |
| ROMACO FRANCE | F11 |
| ROMMELAG | R8 |
| RT2i | K1 |
| SALAMANDERU | F9 |
| SARTORIUS | O1 |
| SCHOTT PHARMA | O20 |
| SCHREINER MEDIPHARM | O49 |
| SCHÜLKE FRANCE | O29 |
| SGD PHARMA | K12 |
| SGS HEALTH SCIENCE | R28 |
| SHERPAPHARMA | K3 |
| SIDJI | O8 |
| SKAN | F3 |
| SOFAST | F2 |
| SOLIDFOG TECHNOLOGIES | R31 |
| SPC GROUP | K11 |
| STÄUBLI | O40 |
| STAXS | KO2 |
| STERILINE | O41 |
| STERIS | R16/R17/R18/R19 |
| SWAN | R3 |
| SYMBIOSE ENVIRONNEMENT | F17/F18 |
| SYNEXIN | O25/R1 |
| SYNTEGON TECHNOLOGY | O39 |
| TECHNIP ENERGIES | R6 |
| TECHNOCHIM | R13 |
| TEG | B3 |
| TELSTAR | O31 |
| TERANGA GROUPE | O15/O35 |
| THERAXEL | R11 |
| VALTRIA | F5 |
| VEOLIA WATER TECHNOLOGIES | R2 |
| WARANET SOLUTIONS | K13 |
| WILCO | R7. |
Registration form
A3P International Congress
Once you have completed this form, you will receive a copy by email
✻
Registration fee : :
Until June 15: 1200€ excl. VAT (VAT20%) + A3P Membership required (additional costs to be expected if you are not yet a member).
From June 16 to September 12: : 1300€ excl. VAT (VAT 20%) + A3P Membership required (additional costs to be expected if you are not yet a member).
From 13 September: 1430€ excl. VAT (VAT 20%) + A3P Membership required (additional costs to be expected if you are not yet a member).
To request a quote, please complete the form and select the “quote” option in the payment information section
To know if you are a member, please contact us.
To know the rates, please refer to the Membership section of the website: https://www.a3p.org/en/membership/
Contact
Depending on your requirements and preferences, you can contact Ludivine BAYLE (exhibition) or Natalina SEMEDO (program & registration):
Phone : +33 (0)4 37 28 30 40
Email : lbayle@a3pservices.com – nsemedo@a3pservices.com
Accessibility
